Guardant Health (GH) Net Cash Flow (2017 - 2026)

Guardant Health has reported Net Cash Flow for 10 years, with the latest figure at $66.7 million in Q2 2026.

• Quarterly Net Cash Flow rose 196.25% year-over-year to $66.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $434.1 million (up 243.89% YoY) and the FY2025 annual result came in at -$140.8 million, up 71.96% from the prior year.
• Net Cash Flow slipped to $66.7 million in Q2 2026 per GH's latest filing, from $612.2 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $675.3 million in Q4 2023 and troughed at -$356.9 million in Q2 2022.
• A 5-year average of $37.8 million and a median of -$10.5 million in 2022 frame the typical range for Net Cash Flow.
• The sharpest annual moves came in 2022 and 2025: Net Cash Flow plunged 614.42% in 2022, then surged 5365.04% in 2025.
• Over 5 years, Net Cash Flow stood at -$17.8 million in 2022, then jumped by 3892.93% to $675.3 million in 2023, then plunged by 108.43% to -$56.9 million in 2024, then plunged by 250.35% to -$199.4 million in 2025, then surged by 133.45% to $66.7 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered $66.7 million, $612.2 million, and -$199.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.